Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: J Addict Med. 2011 Mar;5(1):57–64. doi: 10.1097/ADM.0b013e3181d80c93

TABLE 1.

Demographics, drug use, and psychiatric diagnoses of the participants recorded after randomization at intake (means ± SD)

Variables Citicolinea Placebo
Demographics
Number of subjects 15 14
Raceb 1/0/1/11/2 0/1/0/13/0
Age 38.4 ± 4.5 39.0 ± 5.3
Weight (lbs) 188.2 ± 32.5* 154.9 ± 20.3
Sex (Male/Female) 11/4 7/7
Years of Education 12.6 ± 1.3 12.0 ± 1.6
Age began regular use of cocaine 22.9 ± 5.4 24.7 ± 7.7
Years of regular use of cocaine 15.5 ± 6.1 14.3 ± 6.6
Drug use
Smoked cocaine (instances per week) 3.4 ± 1.9c 4.1 ± 1.9
Snort (intranasal) cocaine (instances per week) 2.8 ± 0.7d 1.8 ± 1.1e
Alcoholic beverages (drinks per week) 12.0 ± 14.2 15.2 ± 21.3
Marihuana cigarettes (per week) 4.0 ± 2.8f 3.9 ± 3.5f
Tobacco cigarettes (per day) 8.5 ± 7.3g 9.1 ± 4.9g
Psychiatric diagnoses
Cocaine dependence 15 14
Alcohol abuse or dependence 7 9
Marihuana abuse or dependence 6 7
Substance abuse induced-mood disorder 1 2
a

1,000 mg/day, p.o

b

Hispanic/American Indian/Cape Verdian/African-American/Caucasian

c

13 out of 15 study participants

d

6 out of 15 study participants

e

2 out of 14 study participants

f

6 study participants in each group

g

11 study participants in each group

*

p<0.05 (t test for independent samples)